ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 736829 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 736829; 2) Community: the network communities that were significantly associated with the response to NSC 736829; 3) Molecule: the relationships between components within communities and NSC 736829; 4) MDR: the compounds that were significantly associated with the NSC 736829.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0236268253072449 -0.17803092
NSC 672120 Oxireno[9,10]cyclodeca[1,2-b]furan-6,9(7H,10aH)-dione, 1a,2,3,7a,8,10b-hexahydro-1a,5-dimethyl-8-methylene-, stereoisomer 0.0236268253072452 0.23472829
NSC 742036 Null 0.0236268253072452 -0.049032423
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0236268253072453 0.3577991
NSC 744688 Null 0.0236268253072453 0.38220103
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.0236268253072453 0.30417644
NSC 755880 Mitomycin (USAN) 0.0236268253072453 0.52644254
NSC 81280 Null 0.0236268253072453 0.0089912122
NSC 10466 Aizen Magenta 0.0246753314031138 0.16576535
NSC 111702 p-Dioxane-2-methanol, 3,5-dihydroxy-6-[6-(methylthio)-9H-purin-9-yl]- 0.0246753314031138 0.43771511
Total:73  Current:44    [First] [Prev] [Next] [Last]